Delivery Order SPE2DB20D1100-SPE2DB23FD2B8
Award Date 8/22/23
Potential Completion Date 8/23/23
Potential Value $7.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,824.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/10 ml vials of nalbuphine hydrochloride. The single delivery order is to be performed by Amerisourcebergen's Conshohocken, Pennsylvania facility between July 10-11, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global...
- The Defense Logistics Agency Troop Support Medical awarded a $1,842 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/10 ml vials of nalbuphine hydrochloride. Performance will take place in Conshohocken, Pennsylvania over one day in early September 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will supply the analgesic drug to the Defense Logistics Agency under this small purchase for medical supplies. No subcontractors or...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,737.08 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 200 mg/10 ml vials of nalbuphine hydrochloride. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by November 2, 2023. No set-aside designation was applied to this order, which was awarded off an existing...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,280 to Amerisourcebergen Drug Corporation for the supply of 200mg/10ml vials of nalbuphine hydrochloride. The single award delivery order was issued against an undisclosed government-wide acquisition contract vehicle and calls for the delivery of 10ml vials of the pharmaceutical product to a facility in Conshohocken, Pennsylvania. Performance is required between September 15-18, 2023. As a major...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $16,814.70 firm fixed price delivery order contract to supply nalbuphine hydrochloride injection to the Defense Logistics Agency Troop Support Medical located in Conshohocken, Pennsylvania. The contract calls for the delivery of 25 packages containing 10 milliliters of nalbuphine hydrochloride injection each, with performance required by January 20, 2022. No set-aside designation was used for this...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,842 to Amerisourcebergen Drug Corporation for Nalbuphine hydrochloride injection. The single award was made against an existing Prime Vendor contract vehicle to supply 10mL vials of the narcotic analgesic medication. Performance will take place at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania, with delivery required by June 22, 2023. No...
- The Defense Logistics Agency awarded a $3,023.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg/10 ml vials of nalbuphine hydrochloride. The single item delivery order was issued under an existing prime vendor contract vehicle and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania by July 19, 2023 to support DLA pharmaceutical procurement programs. No set aside provisions or subcontractors were identified for this...
- The Defense Logistics Agency awarded a delivery order valued at $1,906.23 to AmerisourceBergen Drug Corp for the supply of Nalbuphine 100 mg/10 mL vials on April 29, 2025. This competitively awarded, firm fixed-price delivery order is classified as a non-set-aside contract and carries an ultimate completion date of April 30, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,824.74 firm fixed-price delivery order is for the supply of 10 mL vials of the medication Nalbuphine 200 mg. The contract has a completion date of July 5, 2024 and was awarded on July 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $289.38 delivery order by the Defense Logistics Agency to provide 2 mg/2 ml naloxone syringes. The firm fixed price order is for a one-day period of performance in Conshohocken, Pennsylvania and will support DLA's medical countermeasures procurement programs. No subcontractors or set aside designations were indicated. Amerisourcebergen will deliver the naloxone syringes from its corporate...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FD2B8Delivery Order
The Defense Logistics Agency awarded a $7,262.65 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/10 ml vials of nalbuphine hydrochloride. As the prime contractor, Amerisourcebergen will deliver 10 ml vials of the analgesic drug to a location in Conshohocken, Pennsylvania by August 23, 2023 to fulfill DLA's requirements. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. No subcontractors or set aside designations were identified. This order is likely in support of DLA's medical supply chain responsibilities to provide pharmaceuticals and other health commodities for the U.S. military and other defense agencies.
Generated 12/22/23, 9:18 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 8/22/23 |